These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 34107983)
1. Development of IL-15/IL-15Rα sushi domain-IgG4 Fc complexes in Pichia pastoris with potent activities and prolonged half-lives. Xu H; Shi M; Shao C; Li H; Wu J; Yu Y; Fang F; Guo Y; Xiao W Microb Cell Fact; 2021 Jun; 20(1):115. PubMed ID: 34107983 [TBL] [Abstract][Full Text] [Related]
2. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation. Wu Z; Xu Y J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116 [TBL] [Abstract][Full Text] [Related]
3. Preassociation of IL-15 with IL-15R alpha-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action. Dubois S; Patel HJ; Zhang M; Waldmann TA; Müller JR J Immunol; 2008 Feb; 180(4):2099-106. PubMed ID: 18250415 [TBL] [Abstract][Full Text] [Related]
4. Development of a recombinant human IL-15·sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model. Zhao M; Luo M; Xie Y; Jiang H; Cagliero C; Li N; Ye H; Wu M; Hao S; Sun T; Yang H; Zhang M; Lin T; Lu H; Zhu J Biomed Pharmacother; 2019 Apr; 112():108677. PubMed ID: 30798123 [TBL] [Abstract][Full Text] [Related]
5. Increasing the biological activity of IL-2 and IL-15 through complexing with anti-IL-2 mAbs and IL-15Rα-Fc chimera. Votavova P; Tomala J; Kovar M Immunol Lett; 2014; 159(1-2):1-10. PubMed ID: 24512738 [TBL] [Abstract][Full Text] [Related]
6. Cell-Based IL-15:IL-15Rα Secreting Vaccine as an Effective Therapy for CT26 Colon Cancer in Mice. Thi VAD; Jeon HM; Park SM; Lee H; Kim YS Mol Cells; 2019 Dec; 42(12):869-883. PubMed ID: 31760731 [TBL] [Abstract][Full Text] [Related]
7. NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells. Robinson TO; Hegde SM; Chang A; Gangadharan A; Rivas S; Madakamutil L; Zalevsky J; Miyazaki T; Schluns KS J Clin Invest; 2021 Oct; 131(19):. PubMed ID: 34375310 [TBL] [Abstract][Full Text] [Related]
8. Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15Ralpha complexes. Elpek KG; Rubinstein MP; Bellemare-Pelletier A; Goldrath AW; Turley SJ Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21647-52. PubMed ID: 21098276 [TBL] [Abstract][Full Text] [Related]
9. IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells. Tamzalit F; Barbieux I; Plet A; Heim J; Nedellec S; Morisseau S; Jacques Y; Mortier E Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8565-70. PubMed ID: 24912180 [TBL] [Abstract][Full Text] [Related]
10. The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation. Wu Z; Xue HH; Bernard J; Zeng R; Issakov D; Bollenbacher-Reilley J; Belyakov IM; Oh S; Berzofsky JA; Leonard WJ Blood; 2008 Dec; 112(12):4411-9. PubMed ID: 18796634 [TBL] [Abstract][Full Text] [Related]
11. Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15Rα. Sato N; Sabzevari H; Fu S; Ju W; Petrus MN; Bamford RN; Waldmann TA; Tagaya Y Blood; 2011 Apr; 117(15):4032-40. PubMed ID: 21304101 [TBL] [Abstract][Full Text] [Related]
12. IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization. Han KP; Zhu X; Liu B; Jeng E; Kong L; Yovandich JL; Vyas VV; Marcus WD; Chavaillaz PA; Romero CA; Rhode PR; Wong HC Cytokine; 2011 Dec; 56(3):804-10. PubMed ID: 22019703 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models. Liu B; Jones M; Kong L; Noel T; Jeng EK; Shi S; England CG; Alter S; Miller JS; Cai W; Rhode PR; Wong HC Cytokine; 2018 Jul; 107():105-112. PubMed ID: 29452720 [TBL] [Abstract][Full Text] [Related]
15. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells. Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977 [TBL] [Abstract][Full Text] [Related]
16. Immunobiology of the IL-15/IL-15Rα complex as an antitumor and antiviral agent. Guo Y; Luan L; Patil NK; Sherwood ER Cytokine Growth Factor Rev; 2017 Dec; 38():10-21. PubMed ID: 28888485 [TBL] [Abstract][Full Text] [Related]
17. The exon-3-encoded domain of IL-15ralpha contributes to IL-15 high-affinity binding and is crucial for the IL-15 antagonistic effect of soluble IL-15Ralpha. Bouchaud G; Garrigue-Antar L; Solé V; Quéméner A; Boublik Y; Mortier E; Perdreau H; Jacques Y; Plet A J Mol Biol; 2008 Sep; 382(1):1-12. PubMed ID: 18656487 [TBL] [Abstract][Full Text] [Related]